SEC Form 4 · accession 0001290929-15-000001
AOXING PHARMACEUTICAL COMPANY, INC. · AXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Guoan Zhang
Officer — Vice President
Period of report
Aug 28, 2014
Accepted (ET)
Feb 9, 2015 · 2:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 28, 2014 | A | 831,152 | $0.39 | A | 993,652 | D | |
| Common Stock | Nov 5, 2014 | A | 356,473 | $0.26 | A | 1,350,125 | D |
Table II — derivative securities
No Table II lines on this filing.